Serum paraoxonase activity is decreased in the active stage of Behçet's disease

British Journal of Ophthalmology

Volumn 88, Issue 10, 2004, Pages 1256-1258

  Karakucuk, S ^a   Baskol, G ^a   Oner, A O ^a   Baskol, M ^a   Mirza, E ^a   Ustdal, M ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BEHCET DISEASE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; NEUTROPHIL; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SERUM; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE;

ADULT; ARYLDIALKYLPHOSPHATASE; BEHCET SYNDROME; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED;

EID: 4744358135     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.043398     Document Type: Article

References (24)

1. O'Duffy JD. Vasculitis in Behçet's disease. Rheum Dis Clin N Am 1990;16:423-31.
2. Mochizuki M, Akduman K, Nussenblat RB. Behçet's disease. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection and immunity. St Louis, Mosby, 1996:671-72.
3. Niwa Y, Miyake S, Sakane T, et al. Auto-oxidative damage in Behçet's disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982;49:247-55.
4. Taysi S, Kocer I, Memisogullari R, et al. Serum oxidant/antioxidant status in patients with Behçet's disease. Ann Clin Lab Sci 2002;32:377-82.
5. Dogan P, Soyuer U, Tanrikulu G, et al. Changes in serum and polymorphonuclear antioxidant defense system in Behçet's disease. Invest Dermatol 1989;93:297-8.
6. Loeper J, Ement J, Goy J, et al. Lipid peroxidation during human atherosclerosis. IRCS Med Sci 1983;11:1035-43.
7. Orem A, Deger O, Cimsit G, et al. Plasma lipoprotein (a) and its relationship with disease activity in patients with Behçet's disease. Eur J Clin Chem Clin Biochem 1995;33:473-8.
8. Orem A, Deger O, Memis O, et al. Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease. Ann Rheum Dis 1995;54:726-9.
9. Mitamura T, Ohmo S, Ariga H, et al. Lipoprotein cholesterol concentrations in potients with Behçet's disease. Clin Chim Acta 1988;175:277-84.
10. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:473-80.
11. Mackness B, Durrington PN, Mackness MI. Human serum poraoxonase. Gen Pharmac 1998;31:329-36.
12. Mackness MIS, Mackness PN, Durrington PW, et al. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996;7:69-76.
13. Aviram M, Rosenblat M, Bisgaier CL, et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for poraoxonase. J Clin Invest 1998;101:1581-90.
14. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
15. Jain SK. Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochem Biophys Acta 1998;937:205-10.
16. Eckerson HW, Romson J, Wyte C, et al. The human serum paraoxonase polymorphism: Identification of phenotypes by their response to salts. Am J Hum Genet 1983;35:214-27.
17. Henson PM, Johnston RB. Tissue injury and inflammation. J Clin Int 1987;79:669-74.
18. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721-4.
19. Gutteridge JMC. Free radicals in disease processes: a complication of cause and consequence. Free Radic Res Commun 1993;19:141-58.
20. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993;57(Suppl 1):715S-24S.
21. Halliwell B, Gutteridge JM. Free radicals in biology and medicine. Oxford: Clarendon Press, 1996:1-543.
22. Halliwell B. Reactive oxygen species in living system: source, biochemistry, and role in human disease. Am J Med 1991;91(suppl 3C):14S-22S.
23. Orem A, Efe H, Deger O, et al. Relationship between lipid peroxidation and disease activity in patients with Behçet's disease. J Dermatol Sci 1997;16:11-16.
24. Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999;26:892-904.